These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 20844303)

  • 1. [New insights into the pathogenesis of neuromyelitis optica].
    Misu T; Takahashi T; Nishiyama S; Takano R; Nakashima I; Fujihara K; Itoyama Y
    Brain Nerve; 2010 Sep; 62(9):921-31. PubMed ID: 20844303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
    Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
    Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
    Misu T; Fujihara K; Itoyama Y
    Brain Nerve; 2008 May; 60(5):527-37. PubMed ID: 18516975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuromyelitis optica and anti-aquaporin 4 antibody--distinct from multiple sclerosis].
    Misu T; Takahashi T; Nakashima I; Fujihara K; Itoyama Y
    Rinsho Byori; 2009 Mar; 57(3):262-70. PubMed ID: 19363997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
    Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
    Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [NMO spectrum disorders and anti AQP4 antibody].
    Takai Y; Misu T; Takahashi T; Nakashima I; Fujihara K
    Brain Nerve; 2013 Apr; 65(4):333-43. PubMed ID: 23568981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathology of neuromyelitis optica].
    Misu T
    Rinsho Shinkeigaku; 2009 Nov; 49(11):896-9. PubMed ID: 20030242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromyelitis optica and astrocytic damage in its pathogenesis.
    Fujihara K
    J Neurol Sci; 2011 Jul; 306(1-2):183-7. PubMed ID: 21396661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biomarkers in neuromyelitis optica].
    Misu T; Takahashi T; Nakashima I; Fujihara K
    Brain Nerve; 2012 May; 64(5):525-35. PubMed ID: 22570066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders.
    Kira J
    J Neurol Sci; 2011 Dec; 311(1-2):69-77. PubMed ID: 21962794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [AQP4 immunohistochemistry in neuromyelitis optica and multiple sclerosis: a neuropathological review].
    Yoshida M
    Brain Nerve; 2010 Sep; 62(9):961-74. PubMed ID: 20844307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica.
    Saikali P; Cayrol R; Vincent T
    Autoimmun Rev; 2009 Dec; 9(2):132-5. PubMed ID: 19389490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
    Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y
    Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromyelitis optica: Passive transfer to rats by human immunoglobulin.
    Kinoshita M; Nakatsuji Y; Kimura T; Moriya M; Takata K; Okuno T; Kumanogoh A; Kajiyama K; Yoshikawa H; Sakoda S
    Biochem Biophys Res Commun; 2009 Sep; 386(4):623-7. PubMed ID: 19545538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.
    Takahashi T; Fujihara K; Nakashima I; Misu T; Miyazawa I; Nakamura M; Watanabe S; Shiga Y; Kanaoka C; Fujimori J; Sato S; Itoyama Y
    Brain; 2007 May; 130(Pt 5):1235-43. PubMed ID: 17449477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological autoimmunity targeting aquaporin-4.
    Hinson SR; McKeon A; Lennon VA
    Neuroscience; 2010 Jul; 168(4):1009-18. PubMed ID: 19699271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenesis of neuromyelitis optica].
    Misu T; Fujihara K
    Nihon Rinsho; 2013 May; 71(5):823-8. PubMed ID: 23777089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.
    Marignier R; Ruiz A; Cavagna S; Nicole A; Watrin C; Touret M; Parrot S; Malleret G; Peyron C; Benetollo C; Auvergnon N; Vukusic S; Giraudon P
    J Neuroinflammation; 2016 May; 13(1):111. PubMed ID: 27193196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aquaporin-4 autoantibodies cause asymptomatic aquaporin-4 loss and activate astrocytes in mouse.
    Chan KH; Zhang R; Kwan JS; Guo VY; Ho PW; Ho JW; Chu AC
    J Neuroimmunol; 2012 Apr; 245(1-2):32-8. PubMed ID: 22394609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.